Home FDA denies approval to expanded use of J&J/Bayer's Xarelto
 

Keywords :   


FDA denies approval to expanded use of J&J/Bayer's Xarelto

2013-03-05 06:36:26| Biotech - Topix.net

Johnson & Johnson said health regulators denied approval to an expanded use of its blood thinner, Xarelto, to reduce the risk of heart attacks and strokes in patients with acute coronary syndrome.

Tags: expanded approval fda denies

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.06Atlantic Tropical Weather Outlook
25.06Eastern North Pacific Tropical Weather Outlook
25.06Will there be more air travel chaos this summer?
25.06Bankruptcy trustee plans to shut down Alex Jones' Infowars
25.06Eastern North Pacific Tropical Weather Outlook
25.06Atlantic Tropical Weather Outlook
25.06The screen tech that can do almost anything
25.06Criminal charges recommended against Boeing
More »